HAC
ABBV icon

Harbor Advisory Corp’s AbbVie ABBV Stock Holding History

Harbor Advisory Corp’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.63M Sell
16,702
-2,775
-14% -$616K 1.09% 31
2025
Q4 		$4.45M Sell
19,477
-2,400
-11% -$547K 1.35% 26
2025
Q3 		$5.07M Sell
21,877
-1,535
-7% -$313K 1.5% 23
2025
Q2 		$4.35M Sell
23,412
-118
-0.5% -$21.9K 1.38% 25
2025
Q1 		$4.93M Sell
23,530
-465
-2% -$90.4K 1.65% 22
2024
Q4 		$4.26M Sell
23,995
-150
-0.6% -$27.6K 1.4% 25
2024
Q3 		$4.77M Buy
24,145
+250
+1% +$46.7K 1.56% 24
2024
Q2 		$4.1M Sell
23,895
-1,603
-6% -$266K 1.42% 26
2024
Q1 		$4.64M Sell
25,498
-481
-2% -$82.9K 1.58% 23
2023
Q4 		$4.03M Sell
25,979
-650
-2% -$94.8K 1.44% 25
2023
Q3 		$3.97M Sell
26,629
-312
-1% -$45.8K 1.44% 24
2023
Q2 		$3.63M Sell
26,941
-117
-0.4% -$17.2K 1.28% 30
2023
Q1 		$4.31M Sell
27,058
-955
-3% -$146K 1.65% 23
2022
Q4 		$4.53M Buy
28,013
+760
+3% +$117K 1.85% 21
2022
Q3 		$3.66M Buy
27,253
+2,211
+9% +$317K 1.68% 25
2022
Q2 		$3.83M Buy
25,042
+667
+3% +$102K 1.68% 24
2022
Q1 		$3.95M Sell
24,375
-1,015
-4% -$147K 1.59% 26
2021
Q4 		$3.44M Buy
25,390
+10,682
+73% +$1.26M 1.39% 29
2021
Q3 		$1.59M Buy
14,708
+2,525
+21% +$289K 0.69% 41
2021
Q2 		$1.37M Buy
12,183
+7,700
+172% +$867K 0.62% 43
2021
Q1 		$485K Buy
4,483
+1,500
+50% +$160K 0.19% 78
2020
Q4 		$320K Buy
+2,983
New +$287K 0.17% 75

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Harbor Advisory Corp's ABBV Position: Q1 2026 in Review

Harbor Advisory Corp reduced its AbbVie (ABBV) stake by 14% in Q1 2026, selling an estimated $616K and leaving 16,702 shares worth $3.63M. The position accounts for 1.09% of the portfolio, ranked #31.

Harbor Advisory Corp first reported a position in ABBV in Q4 2020 and has held it in 22 quarters since. The position peaked at $5.07M in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Harbor Advisory Corp held 16,702 shares of AbbVie worth $3.63M as of Q1 2026.
  • Harbor Advisory Corp sold 2,775 AbbVie shares in Q1 2026, an estimated $616K.
  • AbbVie made up 1.09% of Harbor Advisory Corp's portfolio in Q1 2026, its #31 holding.
  • Harbor Advisory Corp first reported a position in AbbVie in Q4 2020 and has held it in 22 quarters since.
  • Harbor Advisory Corp's AbbVie position peaked at $5.07M in Q3 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Harbor Advisory Corp's 13F filing for Q1 2026, filed 7 May 2026.